Home LiteratureArticle Details
PMID: 21754979 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression.

PloS one ·Vol. 6 ·No. 7 ·2011-00-00 ·Pages e20605

Fomchenko EI, Dougherty JD, Helmy KY, Katz AM, Pietras A, Brennan C, Huse JT, Milosevic A, Holland EC

Abstract

Gliomas are thought to form by clonal expansion from a single cell-of-origin, and progression-associated mutations to occur in its progeny cells. Glioma progression is associated with elevated growth factor signaling and loss of function of tumor suppressors Ink4a, Arf and Pten. Yet, gliomas are cellularly heterogeneous; they recruit and trap normal cells during infiltration. We performed lineage tracing in a retrovirally mediated, molecularly and histologically accurate mouse model of hPDGFb-driven gliomagenesis. We were able to distinguish cells in the tumor that were derived from the cell-of-origin from those that were not. Phenotypic, tumorigenic and expression analyses were performed on both populations of these cells. Here we show that during progression of hPDGFb-induced murine gliomas, tumor suppressor loss can expand the recruited cell population not derived from the cell-of-origin within glioma microenvironment to dominate regions of the tumor, with essentially no contribution from the progeny of glioma cell-of-origin. Moreover, the recruited cells can give rise to gliomas upon transplantation and passaging, acquire polysomal expression profiles and genetic aberrations typically present in glioma cells rather than normal progenitors, aid progeny cells in glioma initiation upon transplantation, and become independent of PDGFR signaling. These results indicate that non-cell-of-origin derived cells within glioma environment in the mouse can be corrupted to become bona fide tumor, and deviate from the generally established view of gliomagenesis.

MeSH Terms
AC133 Antigen Animals Antigens, CD/metabolism Cell Movement Cell Transformation, Neoplastic/metabolism,pathology Disease Progression Gene Expression Regulation, Neoplastic Glioma/genetics,pathology Glycoproteins/metabolism Homozygote Humans Mice Neoplasm Transplantation Peptides/metabolism Platelet-Derived Growth Factor/metabolism Receptors, Platelet-Derived Growth Factor/metabolism Signal Transduction Tumor Suppressor Proteins/metabolism
Chemicals
AC133 Antigen Antigens, CD Glycoproteins Peptides Platelet-Derived Growth Factor Tumor Suppressor Proteins Receptors, Platelet-Derived Growth Factor
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Fomchenko Elena I
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Dougherty Joseph D
Helmy Karim Y
Katz Amanda M
Pietras Alexander
Brennan Cameron
Huse Jason T
Milosevic Ana
Holland Eric C
References (42)
42 references, click to expand
  1. The treatment of glioblastoma multiforme.
    Trans Am Neurol Assoc. 1967;92:90-3 PMID: 4329419
  2. Application of a translational profiling approach for the comparative analysis of CNS cell types.
    Cell. 2008 Nov 14;135(4):749-62 PMID: 19013282
  3. A stem cell molecular signature.
    Science. 2002 Oct 18;298(5593):601-4 PMID: 12228721
  4. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
    Neoplasia. 2005 Apr;7(4):356-68 PMID: 15967113
  5. A perivascular niche for brain tumor stem cells.
    Cancer Cell. 2007 Jan;11(1):69-82 PMID: 17222791
  6. Identification of human brain tumour initiating cells.
    Nature. 2004 Nov 18;432(7015):396-401 PMID: 15549107
  7. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
    Oncogene. 1999 Jul 15;18(28):4144-52 PMID: 10435596
  8. Isolation of cancer stem cells from adult glioblastoma multiforme.
    Oncogene. 2004 Dec 16;23(58):9392-400 PMID: 15558011
  9. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.
    Cancer Res. 2004 Jul 15;64(14):4783-9 PMID: 15256447
  10. PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain.
    Glia. 2009 Dec;57(16):1835-47 PMID: 19533602
  11. Cell senescence and a mechanism of clonal evolution leading to continuous cell proliferation, loss of heterozygosity, and tumor heterogeneity: studies on two immortal colon cancer cell lines.
    Cancer Genet Cytogenet. 1996 Sep;90(2):157-65 PMID: 8830727
  12. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
    Cancer Cell. 2006 Mar;9(3):157-73 PMID: 16530701
  13. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.
    Cancer Res. 2004 Oct 1;64(19):7011-21 PMID: 15466194
  14. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.
    Nat Genet. 2000 May;25(1):55-7 PMID: 10802656
  15. Platelet-derived growth factor and its receptor expression in human oligodendrogliomas.
    Neurosurgery. 1998 Feb;42(2):341-6 PMID: 9482185
  16. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
    Oncogene. 2007 Sep 20;26(43):6289-96 PMID: 17438529
  17. Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution.
    Oncogene. 2009 Apr 16;28(15):1807-11 PMID: 19287454
  18. Primary and secondary glioblastomas: from concept to clinical diagnosis.
    Neuro Oncol. 1999 Jan;1(1):44-51 PMID: 11550301
  19. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells.
    Cell Stem Cell. 2010 Feb 5;6(2):141-52 PMID: 20144787
  20. Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.
    J Neuropathol Exp Neurol. 2000 Dec;59(12):1044-50 PMID: 11138924
  21. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses.
    J Neurosci. 2006 Jun 21;26(25):6781-90 PMID: 16793885
  22. Glioma classification: a molecular reappraisal.
    Am J Pathol. 2001 Sep;159(3):779-86 PMID: 11549567
  23. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas.
    Cancer Res. 2008 Apr 1;68(7):2241-9 PMID: 18381430
  24. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.
    Cancer Cell. 2006 May;9(5):391-403 PMID: 16697959
  25. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice.
    Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1218-23 PMID: 9448312
  26. A translational profiling approach for the molecular characterization of CNS cell types.
    Cell. 2008 Nov 14;135(4):738-48 PMID: 19013281
  27. Evidence for clonal origin of neoplastic neuronal and glial cells in gangliogliomas.
    Am J Pathol. 1997 Aug;151(2):565-71 PMID: 9250169
  28. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance.
    J Neuropathol Exp Neurol. 2004 Jul;63(7):700-7 PMID: 15290895
  29. Clonal analysis of gliomas.
    Hum Pathol. 1997 Oct;28(10):1166-79 PMID: 9343324
  30. Identification of a cancer stem cell in human brain tumors.
    Cancer Res. 2003 Sep 15;63(18):5821-8 PMID: 14522905
  31. Microsatellite analysis of primary and recurrent glial tumors suggests different modalities of clonal evolution of tumor cells.
    J Neuropathol Exp Neurol. 2002 May;61(5):396-402 PMID: 12025942
  32. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.
    PLoS One. 2009 Nov 13;4(11):e7752 PMID: 19915670
  33. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling.
    Neuron. 2006 Jul 20;51(2):187-99 PMID: 16846854
  34. Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features.
    J Neuropathol Exp Neurol. 2000 Jun;59(6):495-503 PMID: 10850862
  35. Clonality of oligoastrocytomas.
    Hum Pathol. 2002 May;33(5):528-35 PMID: 12094379
  36. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops.
    Cancer Res. 1992 Jun 1;52(11):3213-9 PMID: 1317261
  37. Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
    Nature. 2008 Oct 23;455(7216):1061-8 PMID: 18772890
  38. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model.
    Nat Med. 2004 Nov;10(11):1257-60 PMID: 15502845
  39. Clonal analysis in glioblastoma with epithelial differentiation.
    Brain Pathol. 2001 Jan;11(1):39-43 PMID: 11145202
  40. Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastoma.
    Brain Tumor Pathol. 2004;21(2):53-6 PMID: 15700833
  41. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors.
    Cancer Res. 1992 Aug 15;52(16):4550-3 PMID: 1322795
  42. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Cancer Res. 2002 Jul 1;62(13):3729-35 PMID: 12097282
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2011-00-00
Epub
2011-00-06
Pages
e20605
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC3130733
Subset
IM
Grants
NINDS NIH HHS · R00 NS067239 · United States
NCI NIH HHS · U54 CA126518 · United States
NCI NIH HHS · U54 CA143798 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]